Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
HealthTronics Announces Successful Recapitalization and New Investment Partnership
HealthTronics, LLC, a leading provider of kidney stone management solutions to urologists, health systems, and patients, announced the successful recapitalization of the company and a new equity investment from Secretariat Capital. This milestone marks the next phase of growth for the company, following strong business performance and operational momentum.
The recapitalization strengthens HealthTronics’ financial position and supports continued investment in its people, technology, and customer solutions.
LookDeep Health Unveils aimee: The First AI Agent in Hospitals
LookDeep, a Silicon Valley AI company focused on hospital care, unveiled aimee, the first staff and patient assistant that combines sight, sound, and language to support patients and work for clinical teams in real time.
Olio taps Healthcare Growth Leader, Nathan Hayes, as Chief Revenue Officer
Olio names Nathan Hayes as Chief Revenue Officer, signaling a major step forward as the company scales for rapid growth and greater impact across healthcare. Hayes brings deep expertise in building and expanding healthcare technology businesses, most recently leading go-to-market teams at Abacus Insights and Inovalon. A proven leader and connector, he is well known for taking products to market and successfully guiding them through periods of hypergrowth.
Molecular You Secures US$5 Million Series A to Scale its Predictive Health Platform
Molecular You, a leader in molecular medicine and preventive health, announced the closing of a $5 million USD Series A financing, led by Voloridge Health, LLC, with participation from Dynamic Leap and others.
American Lung Association Backs Biomarker Testing for Lung Cancer
For people with lung cancer, biomarker testing and targeted therapies can improve treatment outcomes, reduce side effects and help them live longer. Unfortunately, not enough people diagnosed with lung cancer are getting biomarker testing, so the American Lung Association is expanding its Biomarker Education and Awareness for Testing (BEAT) Lung Cancer initiative to increase access to and understanding of biomarker testing, with a particular emphasis on communities bearing the highest lung cancer burden.
To share your insights, please write to us at sudipto@intentamplify.com
